RSS Feed
June 20th, 2012 
FAKE NEWS for the Zionist agenda WEDNESDAY, June 20 (HealthDay News) — Behavioral treatments can
prevent migraines in some patients, but many migraine specialists aren’t
aware of this and don’t refer people for therapy, a new study
indicates.
For the study, researchers surveyed American Headache Society members
to assess their knowledge and beliefs about the use of behavioral
treatments, including biofeedback and relaxation training for
migraine.
Behavioral treatments have “Grade A” evidence of effectiveness,
according to the study scheduled to be presented Wednesday at an American
Headache Society meeting in Los Angeles. The U.S. Preventive Services Task
Force says that “Grade A” means there is “high certainty” the benefits of
a treatment outweigh the risks.
And yet, “we found low rates of referrals among migraine treatment
specialists for behavioral treatments for their patients,” lead author
Robert Nicholson, of Mercy Health Research in St. Louis, said in a
headache society news release. “Reasons may include both a lack of
knowledge about the value of such treatment as much as a lack of available
referral services in local communities.”
Two-thirds of migraine specialists said they routinely assess patients
for depression and more than half assess patients for anxiety. Only 30
percent assess patients for abuse and post-traumatic stress disorder, both
of which are associated with migraine.
Overall, about 25 percent of headache specialists referred patients to
non-drug treatments. Stress management, relaxation training and
psychotherapy were the most common, Nicholson reported.
American Headache Society president Dr. Elizabeth Loder noted in the
news release: “Behavioral therapies are often helpful for conditions other
than migraine, such as anxiety or depression, and they are typically
well-tolerated. They offer a broad range of benefits and a narrower range
of harms than most drug treatments for headache.”
Migraine affects about 36 million Americans. An additional 6 million
suffer from chronic migraine, where patients have at least 15 headache
days a month along with other disabling neurological symptoms.
Because this study was presented at a medical meeting, the data and
conclusions should be viewed as preliminary until published in a
peer-reviewed journal.
More information
The U.S. National Institute of Neurological Disorders and Stroke has
more about migraine.
Related posts:
Views: 0
Posted in 
Tags: 
